A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer
William J. Gradishar(Northwestern University), Virginia Kaklamani(Northwestern University), Tarini Prasad Sahoo(Jawaharlal Nehru Cancer Hospital and Research Centre), D. Lokanatha(Kidwai Memorial Institute of Oncology), Vinod Raina(All India Institute of Medical Sciences), Shailesh Bondarde, Minish Jain(Ruby Hall Clinic), Sunhee Ro, Nathalie A. Lokker, Lee S. Schwartzberg
Cited by 85
Abstract
Related Papers
No related papers found
Powered by citation graph analysis